SCHEMBL17675596

SCHEMBL17675596

O=C(Cl)c1cc2c(nc1Cl)CCCC2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 8/20 0.50
KDM4E B2RXH2 4/20 0.44
SLC9A1 P19634 1/20 0.44
ALDH1A1 P00352 7/20 0.43
MAPT P10636 5/20 0.43
LMNA P02545 4/20 0.43
MAPK1 P28482 3/20 0.43
HSP90AA1 P07900 1/20 0.43
TP53 P04637 1/20 0.41
HTT P42858 1/20 0.41
RAB9A P51151 4/20 0.39
NR2F2 P24468 1/20 0.39
ATM Q13315 1/20 0.39
POLB P06746 2/20 0.38
NPC1 O15118 3/20 0.38
EEF2K O00418 1/20 0.38
GRM1 Q13255 2/20 0.37
PPARG P37231 1/20 0.37
KMT2A Q03164 1/20 0.37
NCOR2 Q9Y618 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23105205 0.98 SMN1; SMN2 (0.49) SMN1; SMN2KDM4ESLC9A1ALDH1A1MAPT
SCHEMBL19454422 0.97 SMN1; SMN2 (0.46) SMN1; SMN2KDM4ESLC9A1ALDH1A1MAPT
SCHEMBL25281642 0.86 POLB (0.51) SMN1; SMN2KDM4ESLC9A1ALDH1A1MAPT
SCHEMBL29377191 0.83 POLB (0.51) SMN1; SMN2KDM4ESLC9A1ALDH1A1MAPT
SCHEMBL682462 0.83 POLB (0.51) SMN1; SMN2KDM4ESLC9A1ALDH1A1MAPT
SCHEMBL12721711 0.81 SMN1; SMN2 (0.47) SMN1; SMN2KDM4ESLC9A1ALDH1A1MAPT
SCHEMBL9871030 0.81 KDM4E (0.50) SMN1; SMN2KDM4ESLC9A1ALDH1A1MAPT
SCHEMBL7913301 0.80 KDM4E (0.49) SMN1; SMN2KDM4ESLC9A1ALDH1A1MAPT
SCHEMBL30681912 0.80 KDM4E (0.49) SMN1; SMN2KDM4ESLC9A1ALDH1A1MAPT
SCHEMBL26618036 0.80 KDM4E (0.49) SMN1; SMN2KDM4ESLC9A1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10626126-B2 Compounds PULMOCIDE LIMITED (GB) 2020-04-21 US disclosed
US-10626126-B2 Compounds PULMOCIDE LIMITED (GB) 2020-04-21 US disclosed
US-20190092791-A1 COMPOUNDS PULMOCIDE LIMITED (GB) 2019-03-28 US disclosed
US-20190092791-A1 COMPOUNDS PULMOCIDE LIMITED (GB) 2019-03-28 US disclosed
US-10189863-B2 5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivatives PULMOCIDE LIMITED (GB) 2019-01-29 US disclosed
US-10189863-B2 5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivatives PULMOCIDE LIMITED (GB) 2019-01-29 US disclosed
EP-3204388-B1 NOVEL 5,6-DIHYDRO-4H-BENZO[B]THIENO-[2,3-D]AZEPINE DERIVATIVES PULMOCIDE LTD (GB) 2018-12-12 EP disclosed
US-20170355717-A1 NOVEL 5,6-DIHYDRO-4H-BENZO[B]THIENO-[2,3-D]AZEPINE DERIVATIVES PULMOCIDE LIMITED (GB) 2017-12-14 US disclosed
US-20170355717-A1 NOVEL 5,6-DIHYDRO-4H-BENZO[B]THIENO-[2,3-D]AZEPINE DERIVATIVES PULMOCIDE LIMITED (GB) 2017-12-14 US disclosed
US-20170355717-A1 NOVEL 5,6-DIHYDRO-4H-BENZO[B]THIENO-[2,3-D]AZEPINE DERIVATIVES PULMOCIDE LIMITED (GB) 2017-12-14 US disclosed
WO-2017175000-A1 COMPOUNDS PULMOCIDE LIMITED (GB) 2017-10-12 WO disclosed
WO-2017175000-A1 COMPOUNDS PULMOCIDE LIMITED (GB) 2017-10-12 WO disclosed
EP-3204388-A1 NOVEL 5,6-DIHYDRO-4H-BENZO[B]THIENO-[2,3-D]AZEPINE DERIVATIVES Pulmocide Limited (GB) 2017-08-16 EP disclosed
WO-2016055792-A1 NOVEL 5,6-DIHYDRO-4H-BENZO[B]THIENO-[2,3-D]AZEPINE DERIVATIVES PULMOCIDE LIMITED (GB) 2016-04-14 WO disclosed
WO-2016055792-A1 NOVEL 5,6-DIHYDRO-4H-BENZO[B]THIENO-[2,3-D]AZEPINE DERIVATIVES PULMOCIDE LIMITED (GB) 2016-04-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10626126-B2 Compounds QDPR, TXNRD2, TXNRD3 SMN1; SMN2 239/4885KDM4E 1377/4885SLC9A1 3383/4885
US-10189863-B2 5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivatives AZI2, HRH4, ZC3HAV1 SMN1; SMN2 347/4885KDM4E 364/4885SLC9A1 3936/4885
US-20190092791-A1 COMPOUNDS QDPR, TXNRD2, TXNRD3 SMN1; SMN2 239/4885KDM4E 1377/4885SLC9A1 3383/4885
US-20170355717-A1 NOVEL 5,6-DIHYDRO-4H-BENZO[B]THIENO-[2,3-D]AZEPINE DERIVATIVES ZC3HAV1, DHX15, AZI2 SMN1; SMN2 560/4885KDM4E 383/4885SLC9A1 3979/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.